Cortica, founded with the mission to revolutionize care for children with developmental disorders, offers comprehensive neurological therapy services. Their vision is to provide personalized, integrative care that addresses the unique needs of each child. Cortica specializes in diagnosing and treating autism, ADHD, developmental delays, and other developmental differences through a combination of in-home, in-clinic, and telehealth services. Their offerings include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and ABA therapy.
Notable figures affiliated with Cortica include experts in neurology and developmental pediatrics who contribute to their innovative approach. The company has received significant investment from healthcare-focused venture capital firms. Key achievements include enabling children to achieve communication and fine motor goals within six months and helping them integrate into general education settings. Cortica's impact is profound, as evidenced by testimonials from parents who have seen remarkable progress in their children's capabilities and independence.
